PGR:NYSE
Progressive Corporation (The)
Data as of 2026-03-09 - not real-time
$206.80
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Progressive Corp (PGR) trades at $206.8, well below its DCF fair value of $472, delivering a compelling valuation gap. The stock sits just above the 20‑day SMA ($207.27) but remains under the 50‑day ($209.57) and 200‑day ($234.57) averages, signaling a short‑term bearish bias. Technical momentum is mixed – the MACD histogram is positive and the signal line is bullish, yet RSI at 46.8 points to neutral pressure and volume is on a downtrend. Fundamentally, PGR posts 12.2% revenue growth, a robust ROE of 40.4%, and generates $11.8 B of free cash flow, supporting its 6.6% dividend yield and a 72% payout ratio. The balance sheet is strong with $10.1 B cash offsetting $7.1 B debt, yielding a low net‑debt profile and a beta of 0.28, indicating limited market volatility exposure. However, a 30‑day volatility of 24.4% and a max drawdown near 31% highlight price swing risks.
Overall, the combination of deep undervaluation, solid cash generation, and a defensive risk profile makes PGR an attractive buy for medium to long horizons, while short‑term positioning should remain cautious amid the bearish trend and waning volume.
Overall, the combination of deep undervaluation, solid cash generation, and a defensive risk profile makes PGR an attractive buy for medium to long horizons, while short‑term positioning should remain cautious amid the bearish trend and waning volume.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 6/10
Key Factors
- price hovering just above the $198.8 support level
- bearish trend indicated by price below SMA200
- decreasing volume suggesting weakening short‑term momentum
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- DCF fair value of $472 implies ~15% upside
- high ROE (40%) and strong free cash flow support earnings sustainability
- attractive 6.6% dividend yield with solid payout coverage
Long Term
> 3 yearsbuy
Conviction: 9/10
Key Factors
- consistent 12% revenue growth and expanding policies in force
- low beta (0.28) provides defensive characteristics in volatile markets
- net‑cash position and disciplined capital management underpin long‑term stability
Key Metrics & Analysis
Financial Health
Revenue Growth12.20%
Profit Margin12.90%
P/E Ratio10.8
ROE40.45%
ROA7.92%
Debt/Equity23.42
P/B Ratio4.0
Op. Cash Flow$17.5B
Free Cash Flow$11.8B
Industry P/E17.4
Technical Analysis
TrendBearish
RSI46.8
Support$198.83
Resistance$214.97
MA 20$207.27
MA 50$209.57
MA 200$234.57
MACDBullish
VolumeDecreasing
Fear & Greed Index75.89
Valuation
Fair Value$472.20
Target Price$238.10
Upside/Downside15.14%
GradeUndervalued
TypeBlend
Dividend Yield6.60%
Risk Assessment
Beta0.28
Volatility24.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.